STOCK TITAN

Global Medical Stock Price, News & Analysis

GMRE NYSE

Welcome to our dedicated page for Global Medical news (Ticker: GMRE), a resource for investors and traders seeking the latest updates and insights on Global Medical stock.

Global Medical REIT Inc. (NYSE: GMRE) is a net-lease medical real estate investment trust that acquires healthcare facilities and leases them to physician groups and regional and national healthcare systems. This news page aggregates company announcements, earnings releases and transaction updates so readers can follow how GMRE manages its healthcare real estate portfolio, capital structure and dividend policy over time.

News items for GMRE often cover quarterly and year-to-date financial results, including rental revenue trends, net income or loss, Funds From Operations (FFO), Adjusted Funds From Operations (AFFO), Funds Available for Distribution (FAD) and same-store cash net operating income. The company also reports portfolio metrics such as occupancy, leasable square footage, annualized base rent, weighted average lease term and the mix of outpatient medical buildings, inpatient rehabilitation facilities, hospitals and other medical real estate.

Investors can use this feed to track Global Medical REIT’s investment activity, such as acquisitions of medical real estate portfolios, property dispositions, and significant leasing events at key facilities. Capital markets and balance sheet developments are another recurring theme, including amendments to the company’s credit facility, interest rate hedging through forward-starting swaps, and offerings of preferred stock like the 8.00% Series B Cumulative Redeemable Preferred Stock.

Governance and corporate actions are also reflected in GMRE’s news, including changes in executive leadership, employment agreements with senior management, board retirements, the authorization of a common stock repurchase program and corporate actions such as the one-for-five reverse stock split of its common stock. For income-focused readers, dividend declarations on common and preferred shares are regularly announced with record and payment details. Bookmark this page to review Global Medical REIT’s latest disclosures and historical announcements in one place.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.14%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
dividends
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.28%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.09%
Tags
-
Rhea-AI Summary

Global Medical REIT Inc. (NYSE: GMRE) announced its plan to release first quarter 2023 financial results after market close on May 3, 2023. The company will hold a conference call on May 4, 2023, at 9:00 a.m. Eastern Time to discuss these results, hosted by CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Interested participants can access the call via a live webcast or through dial-in numbers for both US and international participants. A replay will be available starting at 12:00 p.m. Eastern Time on May 4, through midnight Eastern Time on May 18, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
-
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) announced its 2023 first quarter cash dividends for common and preferred shares. The common cash dividend is set at $0.21 per share, payable on April 11, 2023, to stockholders of record as of March 24, 2023. Additionally, the Series A preferred dividend is $0.46875 per share, to be paid on May 1, 2023, for shareholders on record as of April 15, 2023. This reflects the company's ongoing commitment to return value to shareholders through consistent dividends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.56%
Tags
dividends
Rhea-AI Summary

Global Medical REIT (NYSE: GMRE) reported its financial results for 2022, revealing a 19.6% year-over-year increase in total revenue to $36.3 million in Q4 and $137.3 million for the year. Net income attributable to common stockholders for Q4 was $0.4 million ($0.01 per diluted share) compared to $3.8 million ($0.06 per diluted share) in the prior year. Full-year net income rose to $13.3 million ($0.20 per share) versus $11.8 million ($0.19 per share) previously. The company completed 14 acquisitions totaling $149 million. Rental revenue increased 19.7% to $36.3 million in Q4, despite total expenses climbing to $34.5 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.29%
Tags

FAQ

What is the current stock price of Global Medical (GMRE)?

The current stock price of Global Medical (GMRE) is $35.98 as of February 20, 2026.

What is the market cap of Global Medical (GMRE)?

The market cap of Global Medical (GMRE) is approximately 482.5M.

GMRE Rankings

GMRE Stock Data

482.53M
12.59M
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
BETHESDA

GMRE RSS Feed